Drugs / Infloran
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT07189390 | May 2026 → May 2029 expected | immune dysregulation, neurodevelopmental defects, and colitis | South Australian Health and Medical Research Institute | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01273012 | Apr 2010 → Aug 2011 | acute diarrhea | Phramongkutklao College of Medicine and Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infloran | “Probiotic Infloran® Hard capsules” NCT07189390 ↗ |
| Modality | Other / unclassified | “the probiotic Infloran” NCT01273012 ↗ |
| Route | Oral | “PO bid or tid” NCT01273012 ↗ |